PSI Pre-Clinical SIG Webinar: Update from the Carcinogenicity working group

PSI Introduction to Industry Training (ITIT) Course - 2026/2027

An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.

PSI Career Young Virtual Event (Q1 2026)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

Inclusive and Impactful Conference Contributions

This webinar brings together three bitesize complementary sessions to help PSI contributors create conference presentations and posters that communicate clearly and inclusively. Participants will explore how to refine their message, prepare materials effectively, and adopt practical habits that support confident, accessible delivery. A focused, supportive session designed to elevate every contribution.

AIMS SIG - Open-Source Lunch Bites

Our monthly webinar series allows attendees to gain practical knowledge and skills in open-source coding and tools, with a focus on applications in the pharmaceutical industry. This month’s session, “Graphics Basics,” will introduce the fundamentals of producing graphics using the ggplot2 package.

Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars

Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.

Strategic role of statisticians for JCA

Join our Health Technology Assessment (HTA) European Special Interest Group (ESIG) for a webinar on the strategic role of statisticians in the Joint Clinical Assessment (JCA). The introduction of the JCA marks a new era for evidence generation and market access in Europe. As HTA requirements become more harmonized and methodologically demanding, the role of statisticians has evolved far beyond data analysis. Today, statistical expertise is central to shaping clinical development strategies, designing robust comparative evidence, and ensuring that submissions withstand the scrutiny of EU-level assessors. In this webinar, we explore how statisticians contribute strategically to successful JCA outcomes.

Statisticians in the Age of AI: On Route to Strategic Partnership

A 90-minute webinar featuring two case studies from Bayer and Roche demonstrating how statisticians successfully integrated into AI programs, followed by interactive discussion on strategies for elevating statistical expertise in the AI era.

Enhancing Clinical Study Reporting with the Estimand Framework

Join us for an insightful webinar where we explore practical strategies for applying the estimand framework in clinical study reporting. Drawing on real-world experiences and case studies, we will share recommendations to help you: • Understand the role of estimands in improving transparency and interpretation of trial results. • Navigate common challenges in implementing the framework during reporting. • Apply best practices to enhance regulatory submissions, webposting in public registries (clinicaltrials.gov/CTIS), and scientific publications. Whether you are involved in clinical trial design, data analysis, or regulatory submissions, this session will provide actionable guidance to realize the full potential of the estimand framework.

PSI Career Young Virtual Event (Q2 2026)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

PSI Career Young Virtual Event (Q3 2026)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

PSI Career Young Virtual Event (Q4 2026)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

Speaker	Biography
Steven Bailey Pfizer	Steven Bailey has been supporting Preclinical Drug Safety for 37 years, initially at Wyeth, and more recently at Pfizer. He has provided statistical support and consulting to all areas of drug safety studies, but has particular expertise in carcinogenicity, developmental and reproductive toxicology, juvenile animal studies, and behavioral testing. Steve is a member of a number of Health and Environmental Science Institute (HESI) and International Consortium on Innovation and Quality in the Pharmaceutical Industry (IQ) cross-industry work teams. He has contributed to 2 books on analysis of preclinical animal studies, and has numerous articles to his credit. Steve received a BS in Mathematics and a MS in Statistics from Carnegie-Mellon University. In 2011, Steve was one of the first statisticians in the country to be certified as an 'Accredited Professional Statistician' (PStat) with the American Statistical Association. He is a member of the American Statistical Association and the Teratology Society.

Speaker	Biography
Steven Bailey Pfizer	Steven Bailey has been supporting Preclinical Drug Safety for 37 years, initially at Wyeth, and more recently at Pfizer. He has provided statistical support and consulting to all areas of drug safety studies, but has particular expertise in carcinogenicity, developmental and reproductive toxicology, juvenile animal studies, and behavioral testing. Steve is a member of a number of Health and Environmental Science Institute (HESI) and International Consortium on Innovation and Quality in the Pharmaceutical Industry (IQ) cross-industry work teams. He has contributed to 2 books on analysis of preclinical animal studies, and has numerous articles to his credit. Steve received a BS in Mathematics and a MS in Statistics from Carnegie-Mellon University. In 2011, Steve was one of the first statisticians in the country to be certified as an 'Accredited Professional Statistician' (PStat) with the American Statistical Association. He is a member of the American Statistical Association and the Teratology Society.

Speaker	Biography
Steven Bailey Pfizer	Steven Bailey has been supporting Preclinical Drug Safety for 37 years, initially at Wyeth, and more recently at Pfizer. He has provided statistical support and consulting to all areas of drug safety studies, but has particular expertise in carcinogenicity, developmental and reproductive toxicology, juvenile animal studies, and behavioral testing. Steve is a member of a number of Health and Environmental Science Institute (HESI) and International Consortium on Innovation and Quality in the Pharmaceutical Industry (IQ) cross-industry work teams. He has contributed to 2 books on analysis of preclinical animal studies, and has numerous articles to his credit. Steve received a BS in Mathematics and a MS in Statistics from Carnegie-Mellon University. In 2011, Steve was one of the first statisticians in the country to be certified as an 'Accredited Professional Statistician' (PStat) with the American Statistical Association. He is a member of the American Statistical Association and the Teratology Society.

Speaker	Biography
Steven Bailey Pfizer	Steven Bailey has been supporting Preclinical Drug Safety for 37 years, initially at Wyeth, and more recently at Pfizer. He has provided statistical support and consulting to all areas of drug safety studies, but has particular expertise in carcinogenicity, developmental and reproductive toxicology, juvenile animal studies, and behavioral testing. Steve is a member of a number of Health and Environmental Science Institute (HESI) and International Consortium on Innovation and Quality in the Pharmaceutical Industry (IQ) cross-industry work teams. He has contributed to 2 books on analysis of preclinical animal studies, and has numerous articles to his credit. Steve received a BS in Mathematics and a MS in Statistics from Carnegie-Mellon University. In 2011, Steve was one of the first statisticians in the country to be certified as an 'Accredited Professional Statistician' (PStat) with the American Statistical Association. He is a member of the American Statistical Association and the Teratology Society.

Speaker	Biography
Steven Bailey Pfizer	Steven Bailey has been supporting Preclinical Drug Safety for 37 years, initially at Wyeth, and more recently at Pfizer. He has provided statistical support and consulting to all areas of drug safety studies, but has particular expertise in carcinogenicity, developmental and reproductive toxicology, juvenile animal studies, and behavioral testing. Steve is a member of a number of Health and Environmental Science Institute (HESI) and International Consortium on Innovation and Quality in the Pharmaceutical Industry (IQ) cross-industry work teams. He has contributed to 2 books on analysis of preclinical animal studies, and has numerous articles to his credit. Steve received a BS in Mathematics and a MS in Statistics from Carnegie-Mellon University. In 2011, Steve was one of the first statisticians in the country to be certified as an 'Accredited Professional Statistician' (PStat) with the American Statistical Association. He is a member of the American Statistical Association and the Teratology Society.

Past PSI Events

On this page:

Conferences